Gilead Sciences, Inc.
GILD
$103.17
-$2.98-2.81%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.78B | 1.25B | 1.61B | -4.17B | 1.43B |
| Total Depreciation and Amortization | 693.00M | 690.00M | 694.00M | 690.00M | 688.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.00M | 1.72B | 563.00M | 6.16B | 595.00M |
| Change in Net Operating Assets | 483.00M | 642.00M | -1.55B | -459.00M | -543.00M |
| Cash from Operations | 2.98B | 4.31B | 1.33B | 2.22B | 2.17B |
| Capital Expenditure | -147.00M | -141.00M | -130.00M | -105.00M | -215.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -75.00M | -570.00M | -152.00M | -4.04B | -279.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.00M | 1.00M | -25.00M | 1.94B | -233.00M |
| Cash from Investing | -225.00M | -710.00M | -307.00M | -2.21B | -727.00M |
| Total Debt Issued | 3.46B | -- | -- | -- | 1.00M |
| Total Debt Repaid | -7.00M | -112.00M | -1.85B | -- | 0.00 |
| Issuance of Common Stock | 173.00M | 98.00M | 5.00M | 146.00M | 26.00M |
| Repurchase of Common Stock | -350.00M | -300.00M | -100.00M | -400.00M | -150.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -973.00M | -983.00M | -972.00M | -990.00M | -943.00M |
| Other Financing Activities | -47.00M | -82.00M | -35.00M | -117.00M | -33.00M |
| Cash from Financing | 2.26B | -1.38B | -2.95B | -1.36B | -1.10B |
| Foreign Exchange rate Adjustments | -55.00M | 44.00M | -11.00M | -18.00M | 37.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.96B | 2.26B | -1.95B | -1.37B | 380.00M |